Description
B7-33 has anti-fibrotic effects and is currently being researched as a potential treatment for reducing fibrosis in a variety of diseases. Animal studies have shown that B7-33 can reduce fibrosis by up to 50%, which could lead to improved survival rates in certain cases. B7-33 signals through the relaxin family peptide receptor 1, which is the cognate receptor for relaxin-2
Reviews
There are no reviews yet.